Skip to main content

Conference Correspondent

Omadacycline for Acute Bacterial Skin and Skin Structure Infections: Integrated Analysis of Randomized Clinical Trials

Improved Quality of Life in Adults with Acute Bacterial Skin and Skin Structure Infections with Omadacycline or Linezolid Therapy

Omadacycline In Vitro Activity Against a Molecularly Characterized Collection of Clinical Isolates with Known Tetracycline Resistance Mechanisms

Integrated Safety Summary of Omadacycline, A Novel Aminomethylcycline Antibiotic

Improvements in Remission and Low Disease Activity Achieved with Ongoing Sarilumab Treatment in Patients with RA

Efficacy and Safety of Switching from Adalimumab to Sarilumab in Open-Label Extension of MONARCH Trial in Patients with Active RA

Improvements in PROs with Tofacitinib with and without MTX versus Adalimumab with MTX for the Treatment of RA

Sustained Response Following Discontinuation of MTX in Subcutaneous Tocilizumab-Treated Patients with RA

Longer Duration of Response in MOBILITY Study with Sarilumab plus MTX in Patients with Active, Moderate-to-Severe RA

Cost per Response for Abatacept versus Adalimumab in Patients with Seropositive, Erosive Early RA

1
2
3
4

Page 1 of 8
Results 1 - 10 of 80